NeuroPace (NPCE)
(Delayed Data from NSDQ)
$7.46 USD
+0.07 (0.95%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $7.48 +0.02 (0.27%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NPCE 7.46 +0.07(0.95%)
Will NPCE be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for NPCE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NPCE
NeuroPace (NPCE) Q2 Earnings Beat, '24 Sales View Up
Neuronetics (STIM) Reports Q2 Loss, Lags Revenue Estimates
NPCE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avinger (AVGR) Reports Q2 Loss, Lags Revenue Estimates
Waters (WAT) Q2 Earnings and Revenues Top Estimates
Globus Medical (GMED) Q1 Earnings and Revenues Beat Estimates
Other News for NPCE
NeuroPace (NPCE) Gets a Buy from Lake Street
NeuroPace Strengthens Management Team with Two Key Appointments
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
NeuroPace to Participate in Upcoming Healthcare Conferences in September
NeuroPace: Only For Those With Strong Nerves